How often has Lp(a) evolved?

Clinical Genetics

Volumn 49, Issue 4, 1996, Pages 167-174

  Lawn, Richard M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoliprotein; Lipoprotein; Lp(a)

Indexed keywords

APOLIPOPROTEIN A; LIPOPROTEIN A; PLASMINOGEN; PROTEINASE;

ANIMAL MODEL; ATHEROSCLEROSIS; EVOLUTION; HEART INFARCTION; HEDGEHOG; HUMAN; MULTIGENE FAMILY; NONHUMAN; PHYLOGENY; PRIMATE; PRIORITY JOURNAL; REVIEW; RISK;

ANIMALIA; ERINACEIDAE; PRIMATES;

EID: 0029882980     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1996.tb03281.x     Document Type: Review

References (62)

1. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Seidel D. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: dependence on serum LDL levels. Atherosclerosis 1986: 62: 249-257.
2. Berg K, Dahlen G, Frick MH. Lp(a) Iipoprotein and pre-ß-lipoprotein in patients with coronary heart disease. Clin Genet 1974: 6: 230-235.
3. Berg K. A new serum type system in man - the Lp system. Acta Pathol Microbiol Scand 1963: 59: 369-382.
4. Bostom AG, Gagnon DR, Cupples LA, Wilson PW, Jenner JL, Ordovas JM, Schaefer EJ, Castelli WP. A prospective investigation of elevated lipoprotein(a) detected by electrophoresis and cardiovascular disease in women. Circulation 1994: 90: 1688-1695.
5. Brown MS, Goldstein JL. Plasma lipoproteins: teaching old dogmas new tricks. Nature 1987: 330: 113-114.
6. Byrne CD, Schwartz K, Meer KJ, Cheng JF, Lawn RM. The human apolipoprotein (a)/plasminogen gene cluster contains a novel homologue transcribed in liver. Arterioscler Thromb 1994: 14: 534-541.
7. Byrne CD, Schwartz K, Lawn RM. Loss of a splice donor site at a "skipped exon" in a gene homologous to apolipoprotein(a) leads to an mRNA encoding a protein consisting of a single kringle domain. Arterioscler Thromb Vase Biol 1995: 15: 65-70.
8. Cantin B, Moorjani S, Despres J-P, Dagenias GR, Lupien P-L. Lp(a) in ischemic heart disease: the Quebec Cardiovascular Study. J Am Coll Cardiol 1994: 23: 482A.
9. Castellino FJ, Beals JM.The genetic relationships between kringle domains of human plasminogen, prothrombin, tissue plasminogen activator urokinase and coagulation factor XII. J Mol Evol 1987: 26: 358-369.
10. Castellino FJ, Urano T, deSerrano VS, Beals JM. The structure and activation of plasminogen. In: Scanu AM, ed. Lipoprotein(a). New York: Academic Press, 1990: 87-102.
11. Cremer P, Nagel D, Labrot B, Mann H, Muche R, Elster H, Seidel D. Lipoprotein Lp(a) as predictor of myocardial infarction: results from the prospective Gottingen Risk Incidence and Prevention Study. Eur J Clin Invest 1994: 24: 444-453.
12. Cushing GL, Gaubatz JW, Nava ML, Burdick BJ, Bocan TMA, Guyton JR, Weilbaecher D, DeBakey ME, Lawrie GM, Morrisett JD. Quantitation and localization of apolipoproteins(a) and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis 1989: 9: 593-603.
13. Davie EW. Methods. Enzymology 1981: 80: 153-170.
14. Doolittle RF. Similar amino acid sequences: chance or common ancestry? Science 1981: 214: 14-159.
15. Doolittle RF. The structure and evolution of vertebrate fibrinogen: a comparison of the lamprey and mammalian proteins. Adv Exp Med Biol 1990: 281: 25-37.
16. Durrington PN, Ishola M, Hunt L, Arrol S, Bhatnagar D. Apolipoprotein(a), AI, and B and parental history in men with early onset ischaemic heart disease. Lancet 1988: i: 1070-1073.
17. Genest J Jr, Jenner JL, McNamara JR, Ordovas JM, Silberman SR, Wilson PWF, Schaefer EJ. Prevalence of lipoprotein(a) [Lp(a)] excess in coronary artery disease. Am J Cardiol 1991: 67: 1039-1045.
18. Gilbert W. Why genes in pieces? Nature 1978: 271: 501-502.
19. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 1993: 260: 1655-1658.
20. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is inhibited in apolipoprotein(a) transgenic mice. Nature 1994: 370: 460-462.
21. Han S, Stuart LA, Friezner-Degen SJ. Characterization of the DNF 15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 1991: 30: 9768-9780.
22. Ichinose A. Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis. Biochemistry 1992: 31: 3113-3118.
23. Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Manttari M, Manninen V, Huttunen JK. Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991: 89: 5-67.
24. Lackner C, Cohen JC, Hobbs HH. Molecular definition of the extreme size polymorphism of apolipoprotein(a). Hum Mol Genet 1993: 2: 933-940.
25. Laplaud PM, Beaubatie L, Rail SJ, Luc G, Sbaboureau M. Lipoprotein(a) is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus). J Lipid Res 1988: 29: 1157-1170.
26. Lawn RM, Boonmark NW, Schwartz K, Lindahl GE, Wade WP, Byrne CD, Fong KJ, Meer K, Patthy L. The recurring evolution of Lp(a): insights from cloning of hedgehog apolipoprotein(a). J Biol Chem 1995: 270: 24004-24009.
27. Liu AC, Lawn RM. Vascular interactions of lipoprotein(a). Curr Opin Lipidol 1994: 5: 269-273.
28. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding and plasminogen activation. Arteriosclerosis 1990: 10: 240-245.
29. Magnaghi P, Citterio E, Malgaretti N. Acquati F, Ottolenghi S, Taramelli R. Molecular characterization of the human apo(a)-plasminogen gene family clustered on the telomeric region of chromosome 6(6q26-27). Hum Mol Genet 1994: 3: 437-442.
30. Malgaretti N. Acquati F. Magnaghi P. Bruno L. Pontoglio M. Rocchi M. Saccone S. DellaValle G. D'Urso M. LePaslier D. Ottolenghi S. Taramelli R. Characterization by yeast artificial chromosome cloning of the linked apolipoprotein (a) and plasminogen genes and identification of the apolipoprotein(a) 5′ flanking region. Proc Natl Acad Sci USA 1992: 89: 11584-11588. Malinowski DP. Sadler JE. Davie EW. Characterization of the cDNA coding for human and bovine plasminogen. Biochemistry 1984: 23: 4243-4250.
31. Malgaretti N. Acquati F. Magnaghi P. Bruno L. Pontoglio M. Rocchi M. Saccone S. DellaValle G. D'Urso M. LePaslier D. Ottolenghi S. Taramelli R. Characterization by yeast artificial chromosome cloning of the linked apolipoprotein (a) and plasminogen genes and identification of the apolipoprotein(a) 5′ flanking region. Proc Natl Acad Sci USA 1992: 89: 11584-11588. Malinowski DP. Sadler JE. Davie EW. Characterization of the cDNA coding for human and bovine plasminogen. Biochemistry 1984: 23: 4243-4250.
32. McCance SG. Menhart N. Castellino FJ. Amino acid residues of the kringle-4 and kringle-5 domains of human plasminogen that stabilize their interactions with ω-amino acid ligands. J Biol Chem 1994:269:32405-32410.
33. McLean JW. Tomlinson JE. Kuang WJ. Eaton DL. Chen EY. Fless GM. Scanu AM. Lawn RM. Human apolipoprotein(a): cDNA sequence of an apolipoprotein homologous to plasminogen. Nature 1987: 330: 132-137.
34. Miles LA, Plow EF. Lp(a): an interloper in the fibrinolytic system? Thromb Haemost 1990: 63: 331-335.
35. Nakamura T, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989: 342: 440-443.
36. Naruszewicz M, Selinger E, Davignon J. Oxidative modification of lipoprotein (a) and the effect of beta-carotene. Metabolism 1992: 41: 1215-1224.
37. Naruszewicz M, Selinger E, Dufour R, Davignon J. Probucol protects lipoprotein(a) against oxidative modification. Metabolism 1992: 41: 1225-1228.
38. Novacek MJ. Mammalian phylogeny: shaking the tree. Nature 1992: 356: 121-130.
39. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994: 79: 315-328.
40. Patthy L. Evolution of the proteases of blood coagulation and fibrinolysis by assembly from modules. Cell 1985: 41: 657-663.
41. Patthy L. Introns and exons. Curr Opin Struct Biol 1994: 4: 383-392.
42. Pesole G, Gerardi A, deJaso F, Saccone C. The peculiar evolution of apolipoprotein (a) in human and rhesus macaque. Genetics 1994: 136: 255-260.
43. Pepin JM, O'Neil JA, Hoff HF. Quantification of apo(a) and apoB in human atherosclerotic lesions. J Lipid Res 1991: 32: 317-326.
44. Pustell J, Kafatos FC. A high speed, high capacity homology matrix, Nucl Acids Res 1982: 10: 4765-4782.
45. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989: 9: 579-592.
46. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993: 270: 2195-2199.
47. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993: 362: 801-809.
48. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Widel H. Lipoprotein(a) and coronary heart disease: a prospective 4 case-control study in a population sample of middle-aged men. Br Med J 1990: 301: 1248-1251.
49. Rouy D, Laplaud PM, Saboureau M, Angles-Cano E. Hedgehog lipoprotein(a) is a modulator of activation of plasminogen at the fibrin surface. Arterioscler Thromb 1992: 12: 146-154.
50. Scanu AM, Pfaffinger D, Lee JC, Hinman J. A point mutation (Trp72-Arg) in human apolipoprotein(a) kringle 4-37 associated with a lysine binding defect in Lp(a). Biochim Biophys Acta 1994: 1227: 47-45.
51. Scanu AM, Fless GM. Lipoprotein(a): heterogeneity and biological relevance. J Clin Invest 1990: 85: 1709-1715.
52. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, Abolafia JM, Lippel K, Levy RI. Lipoprotein(a) levels and risk for coronary heart disease in men: the Lipid Research Clinics Primary Prevention Trial. JAMA 1994: 271: 999-1003.
53. Schreiner PJ, Morrisett JD, Sharrett AR, Patsch W, Tyroler HA, Wu K, Heiss G. Lipoprotein (a) as a risk factor for preclinical atherosclerosis. Arterioscler Thromb 1993: 13: 826-833.
54. Sigurdsson G, Baldursdottir A, Sigvaldsonason H, Agnarsson U, Thorgeirsson G, Sigfusson N. Predictive value of apolipoproteins in a prospective study of coronary artery disease in men. Am J Cardiol 1992: 69: 1251-1254.
55. Solymoss BC, Marcil M, Wesolowska E, Gilfix BM, Lesperance J, Campeau L. Relation of coronary artery disease in women <60 years of age to the combined elevation of serum lipoprotein(a) and total cholesterol to high-density cholesterol ratio. Am J Cardiol 1993: 72: 1215-1219.
56. Tomlinson JE, McLean JW, Lawn RM. Rhesus apolipoprotein(a): sequence, evolution and sites of synthesis. J Biol Chem 1989: 264: 5957-5965.
57. Trieu VN, McConathy WJ. Lipoprotein(a) binding to other apolipoprotein B containing lipoproteins. Biochemistry 1990: 29: 5919-5924.
58. Trieu VN, Zioncheck TF, Lawn RM, McConathy WJ. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem 1991: 226: 5480-5485.
59. Utermann G. The mysteries of lipoprotein(a). Science 1989: 246: 904-910.
60. Witzum J L, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991: 88: 1785-1792.
61. Wu TP, Padmanabhan K, Tulinsky, Mulichak AM. The refined structure of the EACA complex of human plasminogen kringle 4. Biochemistry 1991: 30: 10589-10594.
62. Yoshimura T, Yuhki N, Wang MH, Skeel A, Leonard EJ. Cloning, sequencing and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3. J Biol Chem 1993: 268: 15461-15468.